HomeCompareEMCF vs KMB

EMCF vs KMB: Dividend Comparison 2026

EMCF yields 68.61% · KMB yields 5.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMCF wins by $159.73M in total portfolio value
10 years
EMCF
EMCF
● Live price
68.61%
Share price
$31.60
Annual div
$21.68
5Y div CAGR
22.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$159.78M
Annual income
$115,005,568.27
Full EMCF calculator →
KMB
KMB
● Live price
5.25%
Share price
$96.35
Annual div
$5.06
5Y div CAGR
17%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$45.9K
Annual income
$5,222.34
Full KMB calculator →

Portfolio growth — EMCF vs KMB

📍 EMCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMCFKMB
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMCF + KMB cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMCF pays
KMB pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMCF
Annual income on $10K today (after 15% tax)
$5,831.65/yr
After 10yr DRIP, annual income (after tax)
$97,754,733.03/yr
KMB
Annual income on $10K today (after 15% tax)
$446.39/yr
After 10yr DRIP, annual income (after tax)
$4,438.99/yr
At 15% tax rate, EMCF beats the other by $97,750,294.04/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMCF + KMB for your $10,000?

EMCF: 50%KMB: 50%
100% KMB50/50100% EMCF
Portfolio after 10yr
$79.91M
Annual income
$57,505,395.30/yr
Blended yield
71.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on KMB right now

EMCF
No analyst data
KMB
Analyst Ratings
9
Buy
19
Hold
3
Sell
Consensus: Hold
Price Target
$123.00
+27.7% upside vs current
Range: $102.00 — $162.00
Altman Z
3.4
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMCF buys
0
KMB buys
0
No recent congressional trades found for EMCF or KMB in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMCFKMB
Forward yield68.61%5.25%
Annual dividend / share$21.68$5.06
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR22.1%17%
Portfolio after 10y$159.78M$45.9K
Annual income after 10y$115,005,568.27$5,222.34
Total dividends collected$155.59M$21.6K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: EMCF vs KMB ($10,000, DRIP)

YearEMCF PortfolioEMCF Income/yrKMB PortfolioKMB Income/yrGap
1← crossover$19,077$8,376.99$11,314$614.45+$7.8KEMCF
2$38,648$18,236.00$12,867$760.19+$25.8KEMCF
3$83,512$42,158.28$14,713$945.27+$68.8KEMCF
4$193,310$103,951.94$16,924$1,181.90+$176.4KEMCF
5$481,422$274,580.27$19,596$1,486.64+$461.8KEMCF
6$1,295,442$780,320.52$22,850$1,882.16+$1.27MEMCF
7$3,782,179$2,396,056.69$26,849$2,399.80+$3.76MEMCF
8$12,029,694$7,982,762.21$31,812$3,083.36+$12.00MEMCF
9$41,845,044$28,973,271.57$38,033$3,994.72+$41.81MEMCF
10$159,779,766$115,005,568.27$45,918$5,222.34+$159.73MEMCF

EMCF vs KMB: Complete Analysis 2026

EMCFStock

Emclaire Financial Corp operates as the bank holding company for The Farmers National Bank of Emlenton that provides retail and commercial financial products and services to individuals and businesses in western Pennsylvania. The company's deposit products include checking, savings, and term certificate accounts; savings and time deposits; non-interest bearing and interest-bearing demand deposit accounts; and money market accounts. Its loan portfolio comprises one-to-four family mortgage loans, home equity loans, commercial business and commercial real estate loans, consumer loans, and loans to one borrower. The company operates a network of 19 retail branch offices in Venango, Allegheny, Butler, Clarion, Clearfield, Crawford, Elk, Jefferson, and Mercer counties, and Pennsylvania. The company was founded in 1900 and is headquartered in Emlenton, Pennsylvania.

Full EMCF Calculator →

KMBConsumer Staples

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Full KMB Calculator →
📬

Get this EMCF vs KMB comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMCF vs SCHDEMCF vs JEPIEMCF vs OEMCF vs KOEMCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.